168 related articles for article (PubMed ID: 23313308)
1. Peripheral lymphadenopathy as the initial manifestation of malignant mesothelioma in a child.
Gong YS; Rong YT; Han WC; Zhang YC
Hum Pathol; 2013 Apr; 44(4):664-9. PubMed ID: 23313308
[TBL] [Abstract][Full Text] [Related]
2. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases.
Sussman J; Rosai J
Am J Surg Pathol; 1990 Sep; 14(9):819-28. PubMed ID: 2389813
[TBL] [Abstract][Full Text] [Related]
3. Peripheral lymphadenopathy as the initial manifestation of pericardial mesothelioma: a case report.
Yakirevich E; Sova Y; Drumea K; Bergman I; Quitt M; Resnick MB
Int J Surg Pathol; 2004 Oct; 12(4):403-5. PubMed ID: 15494868
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Dilemma: Primary Peritoneal Mesothelioma With Para-Occupational Asbestos Exposure.
Qin KR; Dua D
J Glob Oncol; 2017 Dec; 3(6):828-832. PubMed ID: 29244982
[No Abstract] [Full Text] [Related]
5. Metastatic Malignant Peritoneal Mesothelioma Mimicking an Autoinflammatory Syndrome in a 12-Year-Old Boy.
Olmedilla G; Undaondo C; Vasquez W; Rodriguez N
Pediatr Dev Pathol; 2021; 24(5):478-483. PubMed ID: 33872112
[TBL] [Abstract][Full Text] [Related]
6. Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy.
Sugarbaker PH; Turaga KK; Alexander HR; Deraco M; Hesdorffer M
J Oncol Pract; 2016 Oct; 12(10):928-935. PubMed ID: 27858561
[TBL] [Abstract][Full Text] [Related]
7. Malignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: case series and review of the clinical and immunohistochemical features.
Taşkın S; Gümüş Y; Kiremitçi S; Kahraman K; Sertçelik A; Ortaç F
Int J Clin Exp Pathol; 2012; 5(5):472-8. PubMed ID: 22808303
[TBL] [Abstract][Full Text] [Related]
8. Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: a case report.
Washimi K; Yokose T; Amitani Y; Nakamura M; Osanai S; Noda H; Kawachi K; Takasaki H; Akaike M; Kameda Y
Pathol Int; 2013 Apr; 63(4):220-5. PubMed ID: 23692423
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Platinum Nonresponsive Metastatic Malignant Peritoneal Mesothelioma With Combination Chemoimmunotherapy.
Foote MB; Shia J; Zauderer MG; Nash GM; Cercek A
J Immunother; 2022 Feb-Mar 01; 45(2):100-103. PubMed ID: 34723916
[TBL] [Abstract][Full Text] [Related]
10. [Malignant mesothelioma in the peritoneal cavity - a case report].
Rupert K; Třeška V
Rozhl Chir; 2015 Apr; 94(4):166-9. PubMed ID: 25866103
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological characteristic of metastatic malignant mesothelioma initially diagnosed by lymph node biopsy.
Zhu XL; Gao LM; Li F; Liu WP; Zhang WY; Li GD; Zhang XH; Chen M; Liu XY; Zhao S
Pathol Res Pract; 2017 Jun; 213(6):598-605. PubMed ID: 28551387
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.
Chapel DB; Churg A; Santoni-Rugiu E; Tsujimura T; Hiroshima K; Husain AN
Lung Cancer; 2019 Jan; 127():69-75. PubMed ID: 30642555
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of patients with malignant peritoneal mesothelioma initially presenting as a local inflammation].
Song H; Zheng G; Wei S; Yang Y; Wei X
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):312-3. PubMed ID: 24989921
[No Abstract] [Full Text] [Related]
14. [Diffuse Malignant Peritoneal Mesothelioma with Secondary Liver Invasion Diagnosed Using Laparoscopy - A Case Report].
Yasuda H; Okumura S; Toyoda S; Yamamoto K; Mizumura N; Itou A; Ogawa M; Kawasaki M; Kameyama M
Gan To Kagaku Ryoho; 2018 Mar; 45(3):449-453. PubMed ID: 29650903
[TBL] [Abstract][Full Text] [Related]
15. Diffuse malignant biphasic peritoneal mesothelioma with cystic areas.
Cabibi D; Tutino R; Salamone G; Cocorullo G; Agrusa A; Gulotta G
Ann Ital Chir; 2016 Jun; 87():. PubMed ID: 27320084
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
17. Diffuse malignant peritoneal mesothelioma.
Shih CA; Ho SP; Tsay FW; Lai KH; Hsu PI
Kaohsiung J Med Sci; 2013 Nov; 29(11):642-5. PubMed ID: 24183360
[TBL] [Abstract][Full Text] [Related]
18. A Rare Case of Biphasic Malignant Peritoneal Mesothelioma with Refractory Ascites.
Komaki T; Urata H; Mori K; Iwashita A; Ikeda K; Haraoka S
Intern Med; 2017; 56(7):861-864. PubMed ID: 28381756
[TBL] [Abstract][Full Text] [Related]
19. Malignant peritoneal mesothelioma: contribution and limitation of imaging for its diagnosis.
Marrannes J; Delvaux S; Verheezen J
JBR-BTR; 2009; 92(5):248-50. PubMed ID: 19999328
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
Husain AN; Colby TV; Ordóñez NG; Krausz T; Borczuk A; Cagle PT; Chirieac LR; Churg A; Galateau-Salle F; Gibbs AR; Gown AM; Hammar SP; Litzky LA; Roggli VL; Travis WD; Wick MR
Arch Pathol Lab Med; 2009 Aug; 133(8):1317-31. PubMed ID: 19653732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
